Health Bulletin 9/April/2022

Here are the top health stories for today:

Free PG Medical Courses In Non-Clinical Areas: Telangana   

Contrary to the general notion suggesting that medical courses are extremely expensive in private medical institutes, Telangana-based MediCiti Institute of Medical Sciences (MIMS) and RVM Institute of Medical Sciences & Research Centre (RVMIMS & RC) have started offering PG medical courses for free.

This came as a shock and delight for the aspirants as apart from offering non-clinical postgraduate courses for free, these colleges are also offering free accommodation to the students as a bonus.

For more information, check out the full story on the link below:

Free PG Medical Courses In Non-Clinical Areas: Telangana 

National Medical Commission has power to stop admissions in medical colleges: Supreme Court 

Taking serious cognisance of the NMC inspection report of a Dhule-based medical college which had revealed that the patients in the wards were "hale and hearty" and "no serious in-patient was found in paediatric ward", the Supreme Court has stayed the Bombay High Court order of admissions to 100 MBBS seats at the institute.

Along with the stay on MBBS admissions, the top court has directed the NMC to conduct a fresh surprise inspection of the Annasaheb Chudaman Patil Memorial Medical College by the officers of Professor rank from AIIMS and Maulana Azad Medical College here within two months to see whether it complied with required norms or not.

For more details, check out the full story on the link below:

Supreme Court Stops 100 MBBS Admissions At Maharashtra Medical College, Upholds Power Of NMC To Take Final Call

Serum Institute Covishield booster shot to be available at Rs 600 per shot for individuals above 18 years 

Vaccine maker Serum Institute of India (SII) on Friday said the precaution dose of its Covishield vaccine against COVID-19 will be priced at Rs 600 per shot for eligible individuals.

SII CEO Adar Poonawalla also welcomed the government's move to allow precaution dose of the vaccine to all aged above 18 years at private vaccination centres, saying it will further provide long-term protection against the virus, and aid ease of travel.

"End-users will pay Rs 600 for the booster dose and the hospitals will get at discounted price," Poonawalla said in a statement.

For more information, check out the full story on the link below: 

Serum Institute Covishield Booster Shot To Be Available At Rs 600 Per Shot For Individuals Above 18 Years 

High BMI increases risk of CVDs: India Diabetes: Study 

India Diabetes Study showed that more than 55 percent of newly diagnosed type 2 diabetes mellitus patients in India have low HDL-C (high-density lipid – cholesterol) values,  which could result in developing high risk of developing some form of cardiovascular disease in their lifetime.

The study also suggested that 42 percent of all T2DM patients are at a high risk of hypertension. Mean BMI of the patients was recorded to be 27.2 – classified as overweight as per the Indian Consensus Group guidelines. The study supported by Eris Lifesciences and co-authored by 16 doctors between 2020- 2021, was conducted in partnership with over 1900 physicians and had a sample size of 5080 patients with mean age of 48 years, from across 27 states in India. It has been published in the public library of Science journal.